CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence-Reference-Cited by-同舟云学术

CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence

Published:2016-10-24 Issue:5 Volume:36 Page:606-617
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Garg N,Bakhshinyan D,Venugopal C,Mahendram S,Rosa D A,Vijayakumar T,Manoranjan B,Hallett R,McFarlane N,Delaney K H,Kwiecien J M,Arpin C C,Lai P-S,Gómez-Biagi R F,Ali A M,de Araujo E D,Ajani O A,Hassell J A,Gunning P T,Singh S K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2016235.pdf

Reference55 articles.

1. Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ et al. Medulloblastomics: the end of the beginning. Nat Rev Cancer 2012; 12: 818–834.

2. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 2012; 123: 465–472.

3. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006; 7: 813–820.

4. Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E . Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 2005; 23: 2256–2263.

5. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29: 1408–1414.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights into medulloblastoma relapse;Pharmacology & Therapeutics;2024-08

2. The pivotal role of irradiation‐induced apoptosis in the pathogenesis and therapy of medulloblastoma;Cancer Reports;2024-04

3. Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma;Journal of Experimental & Clinical Cancer Research;2024-01-11

4. STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo;Cancers;2023-04-11

5. Tumorsphere Formation Assay: A Cancer Stem-Like Cell Characterization in Pediatric Brain Cancer Medulloblastoma;Base Excision Repair Pathway;2023